Arctic Bioscience AS reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was NOK 19.08 million compared to NOK 14.4 million a year ago. Revenue was NOK 19.08 million compared to NOK 14.4 million a year ago.

Net loss was NOK 20.66 million compared to NOK 14.95 million a year ago. Basic loss per share from continuing operations was NOK 0.81 compared to NOK 0.61 a year ago.